Write a reviewFor vendors
♡
Home / Investors / Preston Noon

Preston Noon

Venture Fund · Boston

About Preston Noon

Venture capital investor (General Partner, Co-Founder) based in Boston, Massachusetts. Focus areas include Health Care, Genetics, Autoimmune Diseases. Invests at series a stage. Past investments include Entrada Therapeutics, Orchard Therapeutics, Skyhawk Therapeutics.

Investment focus

Stages
Series A
Sectors
Health CareGeneticsAutoimmune DiseasesWellnessWomen FoundedFundraisingEquitiesRare DiseasesLife SciencePortfolio ManagementArtificial Intelligence (AI)FinanceBiotechnologyDrug DevelopmentGenomicsNeuroscienceClinical TrialsMedicalB2BTherapeutics

Portfolio

No portfolio companies recorded yet; Preston Noon reports 13 investments overall.

Similar investors

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Adam Cragg

Angel Investor · Calgary
SeedPre-SeedEarly Stage VentureSeries AAdvertisingHealth CareCybersecurityEnterprise Software+16
60Investments
—Exits

Adam D?Eaugelli

Venture Fund · San Francisco
Early Stage VentureSeries AHealth CareE-commerceSportsWellness+16
60Investments
—Exits

Adam Rothenberg

Angel Investor · New York City
SeedPre-SeedEarly Stage VentureSeries AHealth CareE-commerceMessagingDisruptive Innovation+16
60Investments
—Exits

Adam Valkin

Venture Fund · Newton
Series BEarly Stage VentureSeries AHealth CareDigital TherapeuticsE-commerceAccounting+16
60Investments
—Exits

Adeyemi Ajao

Accelerator · San Francisco
SeedEarly Stage VentureSeries AAdvertisingHealth CareTalent ManagementAutonomous Vehicles+16
60Investments
—Exits